NVDA gained a massive 197% since our AI first added it in November - is it time to sell? 🤔Read more

Why IBM Shares Are Trading Higher; Here Are 21 Stocks Moving Premarket

Published 20/10/2022, 10:55
Why IBM Shares Are Trading Higher; Here Are 21 Stocks Moving Premarket
IBM
-
IXIC
-

Gainers

  • COMSovereign Holding Corp. (NASDAQ: COMS) rose 20.9% to $0.1063 in pre-market trading after dipping 26% on Wednesday. COMSovereign recently announced receipt of Nasdaq listing determination.
  • RedHill Biopharma Ltd. (NASDAQ: RDHL) shares rose 18.1% to $0.8032 in pre-market trading. RedHill Biopharma shares jumped around 47% on Wednesday after the company announced its oral broad-acting antiviral, Opaganib, was granted a new COVID-19 treatment patent.
  • Zovio Inc (NASDAQ: ZVO) shares rose 16.8% to $0.2451 in pre-market trading after gaining 5% on Wednesday.
  • Enservco Corporation (NYSE: ENSV) rose 16.3% to $1.57 in pre-market trading after the company swung to a profit in the first quarter.
  • Vaccitech plc (NASDAQ: VACC) shares rose 8.4% to $3.16 in pre-market trading.
  • Digital Brands Group, Inc. (NASDAQ: DBGI) rose 8.2% to $0.0909 in pre-market trading after dipping over 23% on Wednesday.
  • Pineapple Energy Inc. (NASDAQ: PEGY) rose 7.6% to $4.09 in pre-market trading after dipping over 20% on Wednesday.
  • Mullen Automotive, Inc. (NASDAQ: MULN) rose 7.4% to $0.3651 in pre-market trading. Mullen Automotive shares jumped 57% on Wednesday after the company announced US Bankruptcy Court approval of its acquisition of ELMS assets.
  • Agrify Corporation (NASDAQ: AGFY) rose 7.1% to $2.73 in pre-market trading after dipping around 42% on Wednesday.
  • Minerva Neurosciences, Inc. (NASDAQ: NERV) rose 5.5% to $3.46 in pre-market trading after declining around 14% on Wednesday.
  • International Business Machines Corporation (NYSE: NYSE:IBM) shares rose 3.1% to $126.22 in pre-market trading after the company reported better-than-expected Q3 EPS and sales results.
Don’t forget to check out our premarket coverage here .

Losers

  • Kintara Therapeutics, Inc. (NASDAQ: KTRA) shares fell 15.5% to $0.1020 in pre-market trading after gaining over 20% on Wednesday. The company announced it paused its REM-001 program to conserve funds to support its VAL-083 international registrational study.
  • Telefonaktiebolaget LM Ericsson (BS:ERICAs) (NASDAQ: ERIC) shares fell 15.8% to $5.40 in pre-market trading after reporting Q3 results.
  • Amprius Technologies, Inc. (NASDAQ: AMPX) fell 11.6% to $9.73 in pre-market trading. Amprius Technologies shares jumped 77% on Wednesday after the company announced it was awarded a $50 million cost-sharing grant from the U.S. Department of Energy's Office of Manufacturing and Energy Supply Chains.
  • 180 Life Sciences Corp. (NASDAQ: ATNF) fell 10.8% to $0.4325 in pre-market trading after declining over 6% on Wednesday.
  • Alcoa Corporation (NYSE: NYSE:AA) shares fell 8.8% to $34.30 in pre-market trading after the company reported worse-than-expected Q3 EPS and sales results.
  • Acorda Therapeutics, Inc. (NASDAQ: ACOR) fell 7.5% to $0.5382 in pre-market trading after dipping 20% on Wednesday. Acorda Therapeutics recently announced a $16.5 million award and royalty/supply relief in the AMPYRA arbitration case.
  • Microvast Holdings, Inc. (NASDAQ: MVST) fell 7.2% to $2.07 in pre-market trading. Microvast shares gained 40% on Wednesday after the company was awarded a DOE contract.
  • Tesla, Inc. (NASDAQ: TSLA (NASDAQ:TSLA)) fell 6.6% to $207.50 in pre-market trading. Tesla reported better-than-expected earnings for its third quarter, while sales missed estimates. The company also reported a year over year decrease in Q3 total deliveries.
  • Sunshine Biopharma, Inc. (NASDAQ: SBFM) shares fell 6.3% to $1.20 in pre-market trading after jumping 39% on Wednesday.
  • Nokia Oyj (HE:NOKIA) (NYSE: NOK) shares fell 4% to $4.38 in pre-market trading after reporting Q3 earnings.
© 2022 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Read the original article on Benzinga

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.